Moberg Pharma AB (MOB) - Financial Analysis Review

Summary

Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, develops and commercializes medical products for the treatment of skin diseases. The company offers products such as Emtrix and Nalox or Naloc for the treatment of discolored and deformed nails, Kerasal Nail for discolored and fungus-damaged nails, Kerasal Foot Ointment for dry and cracked heels, Domeboro for minor skin irritations, Blamex for diaper rash for babies and Balmex Adult Care for skin irritation and rash in adults. Moberg Pharma works in collaboration to develop BUPI - Oral mucositis for the treatment of pain in the oral cavity and MOB-015 - Onychomycosis for nail fungus.

GlobalData's Moberg Pharma AB (MOB) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Moberg Pharma AB Key Recent Developments:

Nov 08,2016: Moberg Pharma Interim Report January-September 2016
Nov 04,2016: Moberg Pharmas Nomination Committee Appointed
Aug 09,2016: Moberg Pharma Interim Report January June 2016
May 10,2016: Moberg Pharma: Interim Report January - March 2016
Feb 23,2016: Moberg Pharma Publishes Bond Prospectus and Applies for Listing of Its Bond Loan on Nasdaq Stockholm


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.